Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 93
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 88
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,381 Results (Page 62 of 120)
- Relevance
  Sort by

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
February 2026
262 Pages
Global

From

€6141EUR$6,995USD£5,358GBP

Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032

 Report
March 2024
257 Pages
Global

From

€6584EUR$7,500USD£5,745GBP

Central Nervous System Collaboration and Licensing Deals 2019-2025

 Report
October 2025
500 Pages
Global

From

€3507EUR$3,995USD£3,060GBP

Mouth Ulcers Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

 Report
June 2023
115 Pages
Global

From

€3950EUR$4,500USD£3,447GBP

Autism - Global Clinical Trials Review, 2022

 Clinical Trials
January 2022
419 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Antibody Drug Conjugates Market Report 2025-2035

 Report
December 2024
342 Pages
Global

From

€5160EUR$6,084USD£4,350GBP

Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

 Report
March 2025
384 Pages
Global

From

€4345EUR$4,950USD£3,791GBP

Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4170EUR$4,750USD£3,638GBP

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

 Report
March 2025
1048 Pages
Global

From

€4213EUR$4,799USD£3,676GBP

Rheumatoid Arthritis - Pipeline Review, H2 2020

 Drug Pipelines
July 2020
1191 Pages
Global

From

€2195EUR$2,500USD£1,915GBP

Oncology Precision Medicine Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecasts

 Report
March 2025
468 Pages
Global

From

€4213EUR$4,799USD£3,676GBP

Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033

 Report
June 2023
218 Pages
Global

From

€4686EUR$5,524USD£3,950GBP

Cancer Biologics Market Report 2023-2033

 Report
June 2023
308 Pages
Global

From

€4686EUR$5,524USD£3,950GBP

Biologics - Global Strategic Business Report

 Report
February 2026
293 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Peptide Therapeutics - Global Strategic Business Report

 Report
February 2026
192 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Biological Drugs - Global Strategic Business Report

 Report
February 2026
196 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Targeted Protein Degradation Market - Global Strategic Business Report

 Report
February 2026
384 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Antibody Therapeutics Market - Global Strategic Business Report

 Report
February 2026
577 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Microbial API - Global Strategic Business Report

 Report
February 2026
466 Pages
Global

From

€5136EUR$5,850USD£4,481GBP

Active Pharmaceutical Ingredient (API) Market in the US 2025-2029

 Report
May 2025
177 Pages
United States

From

€2195EUR$2,500USD£1,915GBP

2,381 Results (Page 62 of 120)
- 1
- 60
- 61
- 62
- 63
- 64

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.